Charles Christian Adarkwah

Summary

Country: Germany

Publications

  1. ncbi Cost-effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in newly diagnosed type 2 diabetes in Germany
    Charles Christian Adarkwah
    Institute of Health Economics and Clinical Epidemiology, University of Cologne, Cologne and RWTH University Hospital Aachen, Germany
    Int J Technol Assess Health Care 26:62-70. 2010

Collaborators

Detail Information

Publications1

  1. ncbi Cost-effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in newly diagnosed type 2 diabetes in Germany
    Charles Christian Adarkwah
    Institute of Health Economics and Clinical Epidemiology, University of Cologne, Cologne and RWTH University Hospital Aachen, Germany
    Int J Technol Assess Health Care 26:62-70. 2010
    ..The aim of this study was to assess the most cost-effective time to start an ACE inhibitor (or an angiotensin II receptor blocker in the event of cough) in patients with type 2 diabetes in Germany...